Clevudine therapy for 24 weeks further reduced serum hepatitis B virus DNA levels and increased ALT normalization rates without emergence of viral breakthrough than 12 weeks of clevudine therapy
Kwan Sik Lee, Kwan Soo Byun, Young Hwa Chung, Seung Woon Paik, Joon Yeol Han, Kwon Yoo, Hee Won Yoo, Byung Chul Yoo, Hyo Suk Lee
Research output: Contribution to journal › Article › peer-review
14Scopus
citations
Fingerprint
Dive into the research topics of 'Clevudine therapy for 24 weeks further reduced serum hepatitis B virus DNA levels and increased ALT normalization rates without emergence of viral breakthrough than 12 weeks of clevudine therapy'. Together they form a unique fingerprint.